[House Report 117-208]
[From the U.S. Government Publishing Office]
117th Congress } { Report
HOUSE OF REPRESENTATIVES
1st Session } { 117-208
======================================================================
EARLY HEARING DETECTION AND INTERVENTION ACT OF 2021
_______
December 8, 2021.--Committed to the Committee of the Whole House on the
State of the Union and ordered to be printed
_______
Mr. Pallone, from the Committee on Energy and Commerce, submitted the
following
R E P O R T
[To accompany H.R. 5561]
The Committee on Energy and Commerce, to whom was referred
the bill (H.R. 5561) to reauthorize a program for early
detection, diagnosis, and treatment regarding deaf and hard-of-
hearing newborns, infants, and young children, and for other
purposes, having considered the same, reports favorably thereon
with an amendment and recommends that the bill as amended do
pass.
CONTENTS
Page
I. Purpose and Summary.............................................. 2
II. Background and Need for the Legislation.......................... 3
III. Committee Hearings............................................... 4
IV. Committee Consideration.......................................... 4
V. Committee Votes.................................................. 4
VI. Oversight Findings............................................... 5
VII. New Budget Authority, Entitlement Authority, and Tax Expenditures 5
VIII.Federal Mandates Statement....................................... 5
IX. Statement of General Performance Goals and Objectives............ 5
X. Duplication of Federal Programs.................................. 5
XI. Committee Cost Estimate.......................................... 5
XII. Earmarks, Limited Tax Benefits, and Limited Tariff Benefits...... 5
XIII.Advisory Committee Statement..................................... 5
XIV. Applicability to Legislative Branch.............................. 6
XV. Section-by-Section Analysis of the Legislation................... 6
XVI. Changes in Existing Law Made by the Bill, as Reported............ 7
The amendment is as follows:
Strike all after the enacting clause and insert the
following:
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Early Hearing Detection and
Intervention Act of 2021''.
SEC. 2. REAUTHORIZATION OF PROGRAM FOR EARLY DETECTION, DIAGNOSIS, AND
TREATMENT REGARDING DEAF AND HARD-OF-HEARING
NEWBORNS, INFANTS, AND YOUNG CHILDREN.
Section 399M(f) of the Public Health Service Act (42 U.S.C. 280g-
1(f)) is amended--
(1) in paragraph (1), by striking ``$17,818,000 for fiscal
year 2018, $18,173,800 for fiscal year 2019, $18,628,145 for
fiscal year 2020, $19,056,592 for fiscal year 2021, and
$19,522,758 for fiscal year 2022'' and inserting ``$17,818,000
for each of fiscal years 2022 through 2026'';
(2) in paragraph (2), by striking ``$10,800,000 for fiscal
year 2018, $11,026,800 for fiscal year 2019, $11,302,470 for
fiscal year 2020, $11,562,427 for fiscal year 2021, and
$11,851,488 for fiscal year 2022'' and inserting ``$16,000,000
for each of fiscal years 2022 through 2026''; and
(3) in paragraph (3), by striking ``fiscal years 2011 through
2015'' and inserting ``fiscal years 2022 through 2026''.
SEC. 3. GAO STUDY ON STATE EARLY HEARING DETECTION AND INTERVENTION
PROGRAMS.
(a) In General.--The Comptroller General of the United States shall
conduct a study reviewing State early hearing detection and
intervention (in this section referred to as ``EHDI'') programs. Such
study shall--
(1) analyze how information collected through such programs
informs what is known about EHDI activities to ensure that
newborns, infants, and young children have access to timely
hearing screenings and early interventions, including
information on any disparities in such access;
(2) analyze what is known about how parents use State EHDI
websites to seek health and programmatic guidance related to
their child's hearing loss diagnosis; and
(3) identify efforts and any promising practices of the
Centers for Disease Control and Prevention, the Health
Resources and Services Administration, the National Institute
on Deafness and Other Communication Disorders, and State EHDI
programs--
(A) to address disparities in outreach for, or access
to, timely hearing screenings and early interventions;
and
(B) to ensure that EHDI follow-up services are
communicated and made available to medically
underserved populations, including racial and ethnic
minorities.
(b) Report.--Not later than two years after the date of the enactment
of this Act, the Comptroller General shall--
(1) complete the study under subsection (a) and submit a
report on the results of the study to--
(A) the Committee on Energy and Commerce of the House
of Representatives; and
(B) the Committee on Health, Education, Labor, and
Pensions of the Senate; and
(2) make such report publicly available.
I. Purpose and Summary
H.R. 5561 amends the Public Health Service Act to
reauthorize early detection, diagnosis, and intervention (EHDI)
programs for deaf and hard-of-hearing newborns, infants, and
young children at Health Resources and Services Administration
(HRSA), the Centers for Disease Control and Prevention (CDC),
and the National Institutes for Health (NIH) for fiscal years
2022 through 2026. H.R. 5561 also requires the Comptroller
General of the United States (GAO) to conduct a study within
two years of enactment on current information on EHDI
activities, parent interactions with state EHDI websites, and
best practices for addressing disparities in outreach and
access to timely hearing screenings and early interventions as
well as follow-up services.
II. Background and Need for Legislation
Congenital hearing loss refers to hearing loss that is
present at birth.\1\ It is the most common birth defect with no
currently available cure.\2\ According to recent CDC data, the
prevalence of congenital hearing loss in 2019 was 1.7 per 1,000
babies screened for hearing loss.\3\ Put differently, nearly
6,000 U.S. infants born in 2019 were identified early with
permanent hearing loss.\4\
---------------------------------------------------------------------------
\1\American Speech-Language-Hearing Association, Hearing Loss at
Birth (Congenital Hearing Loss) (https://www.asha.org/public/hearing/
congenital-hearing-loss/) (accessed November 30, 2021).
\2\Justine M. Renauld and Martin L. Basch, Congenital Deafness and
Recent Advances Towards Restoring Hearing Loss, Current Protocols (Mar.
29, 2021) (https://doi.org/10.1002/cpz1.76).
\3\Centers for Disease Control and Prevention, Data and Statistics
About Hearing Loss in Children (June 10, 2021) (https://www.cdc.gov/
ncbddd/hearingloss/data.html).
\4\Id.
---------------------------------------------------------------------------
Undetected and untreated hearing loss is linked with
academic underachievement, as well as delays in speech,
language, social, and emotional development.\5\\6\ For this
reason, timely diagnosis and treatment is critical to ensuring
that all children with hearing loss have the same opportunities
to succeed as their hearing peers. Research has found that
children whose hearing loss is identified by six months of age
have significantly better receptive and expressive skills than
children whose hearing loss is identified later.\7\
Additionally, children identified for hearing loss that receive
treatment within three- to six-months post-birth, respectively,
develop better vocabularies than children who are identified
and treated for hearing loss at later times.\8\
---------------------------------------------------------------------------
\5\See Note 4.
\6\Xidong Deng, Marcus Gaffney, and Scott D. Grosse, Early Hearing
Detection and Intervention in the United States: Achievements and
Challenges in the 21st Century, China CDC Weekly (May 22, 2020)
(https://doi.org/10.46234/ccdcw2020.097).
\7\See Note 3.
\8\Centers for Disease Control and Prevention, Giving Every Child
the Gift of Words (June 21, 2021) (https://www.cdc.gov/ncbddd/
hearingloss/features/feature-vocabulary-hearingloss.html).
---------------------------------------------------------------------------
Hearing loss screening and early intervention were not
regular practice in the early 1990s. Prior to 1993, only one in
10 newborns were screened for hearing loss.\9\ In 2000,
Congress passed and has subsequently reauthorized federal EHDI
programs at HRSA, CDC, and NIH.\10\ These programs support the
development of State and territory programs and systems of care
that identify and support children who are deaf or hard of
hearing by delivering screening, diagnosis, and early
intervention services.\11\ EHDI ensures that children who are
deaf and hard of hearing are identified at an early age through
appropriate newborn, infant, and early childhood screening and
receive optimal intervention care to enhance language,
literacy, cognitive, social, and emotional development.\12\
---------------------------------------------------------------------------
\9\Health Resources and Services Administration, Early Hearing
Detection and Intervention (mchb.hrsa.gov/maternal-child-health-
initiatives/early-hearingdetection-and-intervention.html) (accessed
October 12, 2021).
\10\Hearing Loss Association of America, Early Hearing and
Intervention Act (EHDI) (accessed October 12, 2021) (https://
www.hearingloss.org/programs-events/advocacy/know-your-rights/early-
hearing-detection-intervention-act-ehdi/).
\11\See Note 10.
\12\See Note 9.
---------------------------------------------------------------------------
Rates of EHDI services have significantly increased in the
last 20 years. In 2018, data from CDC reported that 97 percent
of all infants were screened prior to one month of age, 77.1
percent of infants received audiological evaluations and
diagnoses by three months of age, and 70.1 percent of infants
were enrolled in early intervention services before six months
of age.\13\
---------------------------------------------------------------------------
\13\13 Id.
---------------------------------------------------------------------------
H.R. 5561 would extend funding for the EHDI programs
through fiscal year 2026, ensuring that these services would
continue to be available for children that are deaf or hard of
hearing.
III. Committee Hearings
For the purposes of section 3(c) of rule XIII of the Rules
of the House of Representatives, the following hearing was used
to develop or consider H.R. 5561:
The Subcommittee on Health held a legislative hearing on
October 20, 2021, entitled ``Enhancing Public Health:
Legislation to Protect Children and Families.'' The
Subcommittee received testimony from the following witnesses:
Bruce L. Cassis, D.D.S., M.A.G.D.,
President, Academy of General Dentistry;
Raymond DuBois, M.D., Ph.D., Former
President, American Association for Cancer Research;
Donald M. Lloyd-Jones, M.D., Sc.M.,
President, American Heart Association;
Ellyn Miller, President and Founder,
Smashing Walnuts Foundation; and
Rick Nolan, Former U.S. Representative of
Minnesota.
IV. Committee Consideration
Representatives Brett Guthrie (R-KY) and Doris Matsui (D-
CA) introduced H.R. 5561, the ``Early Hearing Detection and
Intervention Act of 2021,'' on October 12, 2021, and it was
referred to the Committee on Energy and Commerce. Subsequently,
on October 13, 2021, H.R. 5561 was referred to the Subcommittee
on Health. A legislative hearing was held on the bill on
October 20, 2021.
On November 4, 2021, the Subcommittee on Health met in open
markup session, pursuant to notice, to consider H.R. 5561 and 8
other bills. No amendments were offered during consideration of
the bill. Upon conclusion of consideration of the bill, the
Subcommittee on Health agreed to report the bill favorably to
the full Committee, without amendment, by a voice vote.
On November 17, 2021, the full Committee met in open markup
session, pursuant to notice, to consider H.R. 5561 and 11 other
bills. During consideration of the bill, an amendment offered
by Representative Matsui was agreed to by a voice vote. Upon
conclusion of consideration of the bill, the full Committee
agreed to a motion on final passage offered by Representative
Pallone (D-NJ), Chairman of the Committee, to order H.R. 5561
reported favorably to the House, amended, by a voice vote.
V. Committee Votes
Clause 3(b) of rule XIII of the Rules of the House of
Representatives requires the Committee to list each record vote
on the motion to report legislation and amendments thereto. The
Committee advises that there were no record votes taken on H.R.
5561.
VI. Oversight Findings
Pursuant to clause 3(c)(1) of rule XIII and clause 2(b)(1)
of rule X of the Rules of the House of Representatives, the
oversight findings and recommendations of the Committee are
reflected in the descriptive portion of the report.
VII. New Budget Authority, Entitlement Authority, and Tax Expenditures
Pursuant to 3(c)(2) of rule XIII of the Rules of the House
of Representatives, the Committee adopts as its own the
estimate of new budget authority, entitlement authority, or tax
expenditures or revenues contained in the cost estimate
prepared by the Director of the Congressional Budget Office
pursuant to section 402 of the Congressional Budget Act of
1974.
The Committee has requested but not received from the
Director of the Congressional Budget Office a statement as to
whether this bill contains any new budget authority, spending
authority, credit authority, or an increase or decrease in
revenues or tax expenditures.
VIII. Federal Mandates Statement
The Committee adopts as its own the estimate of Federal
mandates prepared by the Director of the Congressional Budget
Office pursuant to section 423 of the Unfunded Mandates Reform
Act.
IX. Statement of General Performance Goals and Objectives
Pursuant to clause 3(c)(4) of rule XIII, the general
performance goal or objective of this legislation is to
reauthorize EHDI programs for newborns, infants, and young
children.
X. Duplication of Federal Programs
Pursuant to clause 3(c)(5) of rule XIII, no provision of
H.R. 5561 is known to be duplicative of another Federal
program, including any program that was included in a report to
Congress pursuant to section 21 of Public Law 111-139 or the
most recent Catalog of Federal Domestic Assistance.
XI. Committee Cost Estimate
Pursuant to clause 3(d)(1) of rule XIII, the Committee
adopts as its own the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974.
XII. Earmarks, Limited Tax Benefits, and Limited Tariff Benefits
Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the
Committee finds that H.R. 5561 contains no earmarks, limited
tax benefits, or limited tariff benefits.
XIII. Advisory Committee Statement
No advisory committee within the meaning of section 5(b) of
the Federal Advisory Committee Act was created by this
legislation.
XIV. Applicability to Legislative Branch
The Committee finds that the legislation does not relate to
the terms and conditions of employment or access to public
services or accommodations within the meaning of section
102(b)(3) of the Congressional Accountability Act.
XV. Section-by-Section Analysis of the Legislation
Section 1. Short title
Section 1 designates that the Act may be cited as the
``Early Hearing Detection and Intervention Act of 2021.''
Sec. 2. Reauthorization of program for early detection, diagnosis, and
treatment regarding deaf and hard-of-hearing newborns, infants,
and young children
Section 2 amends the Public Health Service Act to authorize
$17.8 million for programmatic activities at HRSA for each of
fiscal years 2022 through 2026 to award grants or cooperative
agreements to develop statewide newborn, infant, and young
child hearing screening, evaluation, diagnosis, and
intervention programs and systems, as well as provide for the
recruitment, retention, education, and training of qualified
personnel to conduct such activities.
Section 2 also authorizes $16 million for programmatic
activities at CDC for each of fiscal years 2022 through 2026
for grants or cooperative agreements to provide technical
assistance to State agencies or designated entities of States
related to hearing screening, evaluation, diagnosis, and
intervention services.
In addition, Section 2 authorizes such sums as necessary
for programmatic activities at the National Institute on
Deafness and Other Communication Diseases for each of fiscal
years 2022 through 2026 for research and development on the
efficacy of new screening techniques, technology, and
intervention, including clinical studies of screening methods
and other related research.
Sec. 3. GAO study on State Early Hearing Detection and Intervention
programs
Section 3 requires GAO to conduct a study reviewing State
EHDI programs. This study shall (1) analyze how information
collected through State EHDI programs informs what is known
about EHDI activities to ensure newborns, infants, and young
children have access to timely hearing screenings and early
interventions, including information on any disparities in such
access; (2) analyze parent use of State EHDI websites when
seeking health and programmatic guidance related to their
child's hearing loss diagnosis; and (3) identify efforts and
best practices of CDC, HRSA, and the National Institute on
Deafness and Other Communication Disorders, and State EHDI
programs to address disparities in outreach for or access to
timely hearing screenings and early intervention as well as
follow-up services. GAO shall complete the study and issue a
report to the House Committee on Energy and Commerce and the
Senate Committee on Health, Education, Labor, and Pensions
within two years of enactment.
XVI. Changes in Existing Law Made by the Bill, as Reported
In compliance with clause 3(e) of rule XIII of the Rules of
the House of Representatives, changes in existing law made by
the bill, as reported, are shown as follows (existing law
proposed to be omitted is enclosed in black brackets, new
matter is printed in italics, and existing law in which no
change is proposed is shown in roman):
PUBLIC HEALTH SERVICE ACT
* * * * * * *
TITLE III--GENERAL POWERS AND DUTIES OF PUBLIC HEALTH SERVICE
* * * * * * *
PART P--ADDITIONAL PROGRAMS
* * * * * * *
SEC. 399M. EARLY DETECTION, DIAGNOSIS, AND TREATMENT REGARDING DEAF AND
HARD-OF-HEARING NEWBORNS, INFANTS, AND YOUNG
CHILDREN.
(a) Statewide Newborn, Infant, and Young Child Hearing
Screening, Evaluation and Intervention Programs and Systems.--
The Secretary, acting through the Administrator of the Health
Resources and Services Administration, shall make awards of
grants or cooperative agreements to develop statewide newborn,
infant, and young child hearing screening, evaluation,
diagnosis, and intervention programs and systems, and to assist
in the recruitment, retention, education, and training of
qualified personnel and health care providers (including, as
appropriate, education and training of family members), for the
following purposes:
(1) To develop and monitor the efficacy of statewide
programs and systems for hearing screening of newborns,
infants, and young children (referred to in this
section as ``children''); prompt evaluation and
diagnosis of children referred from screening programs;
and appropriate educational, audiological, medical, and
communication (or language acquisition) interventions
(including family support), for children identified as
deaf or hard-of-hearing, consistent with the following:
(A) Early intervention includes referral to,
and delivery of, information and services by
organizations such as schools and agencies
(including community, consumer, and family-
based agencies), in health care settings
(including medical homes for children), and in
programs mandated by part C of the Individuals
with Disabilities Education Act, which offer
programs specifically designed to meet the
unique language and communication needs of deaf
and hard-of-hearing children.
(B) Information provided to families should
be accurate, comprehensive, up-to-date, and
evidence-based, as appropriate, to allow
families to make important decisions for their
children in a timely manner, including
decisions with respect to the full range of
assistive hearing technologies and
communications modalities, as appropriate.
(C) Programs and systems under this paragraph
shall offer mechanisms that foster family-to-
family and deaf and hard-of-hearing consumer-
to-family supports.
(2) To continue to provide technical support to
States, through one or more technical resource centers,
to assist in further developing and enhancing State
early hearing detection and intervention programs.
(3) To identify or develop efficient models
(educational and medical) to ensure that children who
are identified as deaf or hard-of-hearing through
screening receive follow-up by qualified early
intervention providers or qualified health care
providers (including those at medical homes for
children), and referrals, as appropriate, including to
early intervention services under part C of the
Individuals with Disabilities Education Act. State
agencies shall be encouraged to effectively increase
the rate of such follow-up and referral.
(b) Technical Assistance, Data Management, and Applied
Research.--
(1) Centers for disease control and prevention.--
(A) In general.--The Secretary, acting
through the Director of the Centers for Disease
Control and Prevention, shall make awards of
grants or cooperative agreements to provide
technical assistance to State agencies or
designated entities of States--
(i) to develop, maintain, and improve
data collection systems related to
newborn, infant, and young child
hearing screening, evaluation
(including audiologic, medical, and
language acquisition evaluations),
diagnosis, and intervention services;
(ii) to conduct applied research
related to newborn, infant, and young
child hearing screening, evaluation,
and intervention programs and outcomes;
(iii) to ensure quality monitoring of
hearing screening, evaluation, and
intervention programs and systems for
newborns, infants, and young children;
and
(iv) to support newborn, infant, and
young child hearing screening,
evaluation, and intervention programs,
and information systems.
(B) Use of awards.--The awards made under
subparagraph (A) may be used--
(i) to provide technical assistance
on data collection and management,
including to coordinate and develop
standardized procedures for data
management;
(ii) to assess and report on the cost
and program effectiveness of newborn,
infant, and young child hearing
screening, evaluation, and intervention
programs and systems;
(iii) to collect data and report on
newborn, infant, and young child
hearing screening, evaluation,
diagnosis, and intervention programs
and systems for applied research,
program evaluation, and policy
improvement;
(iv) to identify the causes and risk
factors for congenital hearing loss;
(v) to study the effectiveness of
newborn, infant, and young child
hearing screening, audiologic and
medical evaluations and intervention
programs and systems by assessing the
health, intellectual and social
developmental, cognitive, and hearing
status of these children at school age;
and
(vi) to promote the integration and
interoperability of data regarding
early hearing loss across multiple
sources to increase the flow of
information between clinical care and
public health settings, including the
ability of States and territories to
exchange and share data.
(2) National institutes of health.--The Director of
the National Institutes of Health, acting through the
Director of the National Institute on Deafness and
Other Communication Disorders, shall for purposes of
this section, continue a program of research and
development on the efficacy of new screening techniques
and technology, including clinical studies of screening
methods, studies on efficacy of intervention, and
related research.
(c) Coordination and Collaboration.--
(1) In general.--In carrying out programs under this
section, the Administrator of the Health Resources and
Services Administration, the Director of the Centers
for Disease Control and Prevention, and the Director of
the National Institutes of Health shall collaborate and
consult with--
(A) other Federal agencies;
(B) State and local agencies, including
agencies responsible for early intervention
services pursuant to title XIX of the Social
Security Act (Medicaid Early and Periodic
Screening, Diagnosis and Treatment Program);
title XXI of the Social Security Act (State
Children's Health Insurance Program); title V
of the Social Security Act (Maternal and Child
Health Block Grant Program); and part C of the
Individuals with Disabilities Education Act;
(C) consumer groups of, and that serve,
individuals who are deaf and hard-of-hearing
and their families;
(D) appropriate national medical and other
health and education specialty organizations;
(E) individuals who are deaf or hard-of-
hearing and their families;
(F) other qualified professional personnel
who are proficient in deaf or hard-of-hearing
children's language and who possess the
specialized knowledge, skills, and attributes
needed to serve deaf and hard-of-hearing
children, and their families;
(G) third-party payers and managed care
organizations; and
(H) related commercial industries.
(2) Policy development.--The Administrator of the
Health Resources and Services Administration, the
Director of the Centers for Disease Control and
Prevention, and the Director of the National Institutes
of Health shall coordinate and collaborate on
recommendations for policy development at the Federal
and State levels and with the private sector, including
consumer, medical and other health and education
professional-based organizations, with respect to
newborn and infant hearing screening, evaluation,
diagnosis, and intervention programs and systems.
(3) State early detection, diagnosis, and
intervention programs and systems; data collection.--
The Administrator of the Health Resources and Services
Administration and the Director of the Centers for
Disease Control and Prevention shall coordinate and
collaborate in assisting States--
(A) to establish newborn, infant, and young
child hearing screening, evaluation, diagnosis,
and intervention programs and systems under
subsection (a); and
(B) to develop a data collection system under
subsection (b).
(d) Rule of Construction; Religious Accommodation.--Nothing
in this section shall be construed to preempt or prohibit any
State law, including State laws that do not require the
screening for hearing loss of children of parents who object to
the screening on the grounds that such screening conflicts with
the parent's religious beliefs.
(e) Definitions.--For purposes of this section:
(1) The term ``audiologic'', when used in connection
with evaluation, means procedures--
(A) to assess the status of the auditory
system;
(B) to establish the site of the auditory
disorder, the type and degree of hearing loss,
and the potential effects of hearing loss on
communication; and
(C) to identify appropriate treatment and
referral options, including--
(i) linkage to State coordinating
agencies under part C of the
Individuals with Disabilities Education
Act or other appropriate agencies;
(ii) medical evaluation;
(iii) assessment for the full range
of assistivehearing technologies
appropriate for newborns, infants, and
young children;
(iv) audiologic rehabilitation
treatment; and
(v) referral to national and local
consumer, self-help, parent, family,
and education organizations, and other
family-centered services.
(2) The term ``early intervention''means--
(A) providing appropriate services for the
child who is deaf or hard-of-hearing, including
nonmedical services; and
(B) ensuring that the family of the child
is--
(i) provided comprehensive, consumer-
oriented information about the full
range of family support, training,
information services, and language
acquisition in oral and visual
modalities; and
(ii) given the opportunity to
consider and obtain the full range of
such appropriate services, educational
and program placements, and other
options for the child from highly
qualified providers.
(3) The term ``medical evaluation''means key
components performed by a physician including history,
examination, and medical decision making focused on
symptomatic and related body systems for the purpose of
diagnosing the etiology of hearing loss and related
physical conditions, and for identifying appropriate
treatment and referral options.
(4) The term ``medical intervention''means the
process by which a physician provides medical diagnosis
and direction for medical or surgical treatment options
for hearing loss or other medical disorders associated
with hearing loss.
(5) The term ``newborn, infant, and young child
hearing screening'' means objective physiologic
procedures to detect possible hearing loss and to
identify newborns, infants, and young children under 3
years of age who require further audiologic and medical
evaluations.
(f) Authorization of Appropriations.--
(1) Statewide newborn and infant hearing screening,
evaluation and intervention programs and systems.--For
the purpose of carrying out subsection (a), there are
authorized to be appropriated to the Health Resources
and Services Administration [$17,818,000 for fiscal
year 2018, $18,173,800 for fiscal year 2019,
$18,628,145 for fiscal year 2020, $19,056,592 for
fiscal year 2021, and $19,522,758 for fiscal year 2022]
$17,818,000 for each of fiscal years 2022 through 2026.
(2) Technical assistance, data management, and
applied research; centers for disease control and
prevention.--For the purpose of carrying out subsection
(b)(1), there are authorized to be appropriated to the
Centers for Disease Control and Prevention [$10,800,000
for fiscal year 2018, $11,026,800 for fiscal year 2019,
$11,302,470 for fiscal year 2020, $11,562,427 for
fiscal year 2021, and $11,851,488 for fiscal year 2022]
$16,000,000 for each of fiscal years 2022 through 2026.
(3) Technical assistance, data management, and
applied research; national institute on deafness and
other communication disorders.--For the purpose of
carrying out subsection (b)(2), there are authorized to
be appropriated to the National Institute on Deafness
and Other Communication Disorders such sums as may be
necessary for [fiscal years 2011 through 2015] fiscal
years 2022 through 2026.
* * * * * * *
[all]